Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation
Addolorata Maria Luce Coluccia(University of Bari Aldo Moro), Carlo Gambacorti‐Passerini(Azienda Ospedaliera San Gerardo)
Cited by 214
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase
|Journal of Biological Chemistry|2007|75
Inhibition of RET tyrosine kinase by SU5416
|Journal of Molecular Endocrinology|2006|54